Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy-Reference-Cited by-同舟云学术

Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy

Published:2023-05-29 Issue:11 Volume:13 Page:1905
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Mondini Lucrezia¹^ORCID,Confalonieri Paola¹^ORCID,Pozzan Riccardo¹,Ruggero Luca¹,Trotta Liliana¹,Lerda Selene²,Hughes Michael³^ORCID,Bellan Mattia⁴⁵⁶^ORCID,Confalonieri Marco¹^ORCID,Ruaro Barbara¹^ORCID,Salton Francesco¹^ORCID,Tavano Stefano¹^ORCID

Affiliation:

1. Pulmonology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy

2. Graduate School, University of Milan, 20149 Milano, Italy

3. Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester M6 8HD, UK

4. Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy

5. Center for Autoimmune and Allergic Disease (CAAD), Università del Piemonte Orientale (UPO), 28100 Novara, Italy

6. Azienda Ospedaliero–Universitaria, Maggiore della Carità, 28100 Novara, Italy

Abstract

COVID-19 is a multisystemic disease that mainly affects and causes dysregulation of the endothelium, causing systemic manifestations. A nailfold video capillaroscopy is a safe, easy, and noninvasive method to evaluate microcirculation alteration. In this review, we analyzed the literature available to date regarding the object of nailfold video capillaroscopy (NVC) use in patients with a SARS-CoV-2 infection, both in the acute phase and after discharge. The scientific evidence pointed out the main alterations in capillary circulation shown by NVC, so reviewing the findings of each article allowed us to define and analyze the future prospects and needs for possibly including NVC within the management of patients with COVID-19, both during and after the acute phase.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/13/11/1905/pdf

Reference55 articles.

1. (2023, March 11). Timeline: WHO’s COVID-19 Response. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline.

2. World Health Organization (2023). Therapeutics and COVID-19: Living Guideline, 13 January 2023, World Health Organization.

3. ESCMID Rapid Guidelines for Assessment and Management of Long COVID;Yelin;Clin. Microbiol. Infect.,2022

4. Cytokine Elevation in Severe and Critical COVID-19: A Rapid Systematic Review, Meta-Analysis, and Comparison with Other Inflammatory Syndromes;Leisman;Lancet Respir. Med.,2020

5. Host-Based Treatments for Severe COVID-19;Mondini;CIMB,2023

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the diagnostic and prognostic ability of ischemia modified albumin in COVID-19;Heart & Lung;2024-06

2. Nailfold videocapillaroscopy findings in COVID-19: a new mimicker of the scleroderma pattern?;Rheumatology;2024-05-03

3. Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go?;Diagnostics;2024-04-30

4. Comparison of nailfold capillaroscopy findings in COVID-19 survivors with and without rheumatic disease: a case-control study;Cukurova Medical Journal;2024-03-29

5. Baseline capillaroscopy provides no evidence of microvascular changes to predict long-COVID syndrome;Bratislava Medical Journal;2024